Financhill
Back

Milestone Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47

MIST
Milestone Pharmaceuticals, Inc.

Last Price:
$2.09
Seasonality Move:
-12.37%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bearish and MIST is experiencing slight buying pressure.

Milestone Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.37 Sell
20-day SMA: 2.5 Sell
50-day SMA: 2.18 Sell
200-day SMA: 1.76 Buy
8-day EMA: 2.3 Sell
20-day EMA: 2.37 Sell
50-day EMA: 2.06 Buy
200-day EMA: 0.96 Buy

Milestone Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 42.06 Sell
Chaikin Money Flow: 1229199 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.23 - 2.69) Sell
Bollinger Bands (100): (1.67 - 2.33) Buy

Milestone Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Milestone Pharmaceuticals, Inc. Stock

Is Milestone Pharmaceuticals, Inc. Stock a Buy?

MIST Technical Analysis vs Fundamental Analysis

Sell
47
Milestone Pharmaceuticals, Inc. (MIST) is a Sell

Is Milestone Pharmaceuticals, Inc. a Buy or a Sell?

Milestone Pharmaceuticals, Inc. Stock Info

Market Cap:
183.1M
Price in USD:
2.15
Share Volume:
5.8M

Milestone Pharmaceuticals, Inc. 52-Week Range

52-Week High:
3.06
52-Week Low:
0.63
Sell
47
Milestone Pharmaceuticals, Inc. (MIST) is a Sell

Milestone Pharmaceuticals, Inc. Share Price Forecast

Is Milestone Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Milestone Pharmaceuticals, Inc.

Is Milestone Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.12 per share.

Technical Analysis of Milestone Pharmaceuticals, Inc.

Should I short Milestone Pharmaceuticals, Inc. stock?

* Milestone Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.